ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Waiting lists"

  • 2022 American Transplant Congress

    Physiological Age by Artificial Intelligence-Enhanced Electrograms as a Novel Biomarker of Mortality in Kidney Transplant Candidates

    E. Lorenz, I. Zaniletti, B. Johnson, T. Petterson, W. Kremers, C. Schinstock, H. Amer, A. Cheville, N. LeBrasseur, A. Baez-Suarez, Z. Attia, F. Lopez-Jimenez, P. Friedman, C. Kennedy, A. Rule

    Mayo Clinic, Rochester, MN

    *Purpose: Assessing mortality risk prior to kidney transplantation is challenging. Age-Gap, which is the difference between physiological age determined by artificial intelligence-enhanced electrocardiograms (ECG) and…
  • 2022 American Transplant Congress

    Status Exception Use in the New Seven-Tiered Heart Allocation System

    A. Plana1, A. Kanelidis1, W. F. Parker2, V. Jeevanandam3, C. Salerno3, B. Smith1, S. Kalantari1, S. Pinney1, J. Grinstein1

    1Cardiology, University of Chicago, Chicago, IL, 2Pulmonary/Critical Care, University of Chicago, Chicago, IL, 3Cardiac Surgery, University of Chicago, Chicago, IL

    *Purpose: The revised seven-tiered US heart allocation policy aimed to improve risk stratification to lower exception status use. However, recent literature has demonstrated that exceptions…
  • 2022 American Transplant Congress

    Survival Comparison of Waitlisted and Renal Transplanted Patients in the European Senior Programme

    M. G. Naik1, V. Greese1, K. U. Eckardt1, U. Frei1, P. Glander1, L. Liefeldt1, M. Pigorsch2, E. Schaeffner3, K. Budde1, F. Halleck1

    1Medical Department, Division of Nephrology and Internal Intensive Care Medicine, Charité, Berlin, Germany, 2Institute of Biometry and Clinical Epidemiology, Charité, Berlin, Germany, 3Institute of Public Health, Charité, Berlin, Germany

    *Purpose: Patients >65years are eligible for kidney transplantation (KT) in the European Senior Program (ESP). We compare patient survival of waitlisted (WTL) and transplanted (Tx)…
  • 2022 American Transplant Congress

    Less is More. Extensive Cardiac Investigations Add Little Value in Waitlisting Patients for Kidney Transplantation

    B. Chow1, M. Khurram2, E. Capuano2, F. Pugliese2, M. Yaqoob2, I. Mohamed2

    1Barts and the London School of Medicine and Dentistry, London, United Kingdom, 2Department of Renal and Transplantation, Royal London Hospital, Bart's Health NHS Trust, London, United Kingdom

    *Purpose: Extensive cardiac investigations have long been considered necessary to aid decision-making in waitlisting for kidney transplantation. However, the utility and reliability of such comprehensive…
  • 2022 American Transplant Congress

    Demographic Characteristics of VCA Candidates and Recipients in the U.S.

    J. Wainright1, L. Cartwright1, A. Henderson1, W. Cherikh1, S. Booker1, D. Klassen2

    1Research, UNOS, Richmond, VA, 2Office of the Chief Medical Officer, UNOS, Richmond, VA

    *Purpose: As with other fields of transplantation, it is important to understand the populations VCA transplantation is serving.*Methods: This study used OPTN VCA waiting list…
  • 2022 American Transplant Congress

    Multicenter Effort Assessing the Effects of COVID Infection and Vaccination on HLA Antibodies in Waitlisted Patients with ESRD

    G. R. Roll1, M. Cooper2, H. Gebel3, K. M. Hitchman4, M. Hobeika5, J. Houp6, M. Kamoun7, J. Killian8, J. Kim9, V. Kumar10, M. Levine11, T. Lunow-Luke1, R. Parsons12, D. Ranch13, P. Stock14, S. Yi15, R. Rajalingam16

    1UCSF Medical Center, San Francisco, CA, 2MedStar Georgetown Transplant Institute, Washington, DC, 3Emory University Hospital, Atlanta, GA, 4Pathology and Laboratory Medicine, University of Texas Health San Antonio, San Antonio, TX, 5Houston Methodist, Houston, TX, 6University of Alabama, Birmingham, AL, 7Hospital Univ of Pennsylvania, Philadelphia, PA, 8University of Alabama at Birmingham, Birmingham, AL, 9Surgery, Keck Medicine of USC, Los Angeles, CA, 10University of Alabama at Birmingham Hospital, Birmingham, AL, 11University of Pennsylvania, Philadelphia, Pe, 12Emory University School of Medicine, Atlanta, GA, 13UT Health San Antonio, San Antonio, TX, 14Univ of California-San Francisco, San Francisco, CA, 15Houston Methodist Hospital, Houston, TX, 16Immunogenetics and Transplantation Laboratory (ITL), San Francisco, CA

    *Purpose: Although rare, infection and vaccination have been reported to result in human leukocyte antibodies (HLA). We analyzed the effect of SARS-CoV2 infection, or COVID-19…
  • 2022 American Transplant Congress

    Social Determinants of Health Impact Successful Listing for Liver and Kidney Transplant

    J. B. Henson, D. Mohottige, J. M. Wilder, A. J. Muir, L. M. McElroy

    Duke University, Durham, NC

    *Purpose: To evaluate the association between community socioeconomic disadvantage and structural social determinants of health (SDOH) on successful listing for liver (LT) and kidney transplantation…
  • 2022 American Transplant Congress

    Prediction of Waitlist Mortality in Liver Transplant Candidates: Do Time-Varying Models Help?

    A. Kwong1, W. Kim1, D. Schladt2, A. Wey2, J. Snyder2, A. Israni2, J. Lake3

    1Stanford University, Stanford, CA, 2Hennepin Healthcare Research Institute, Minneapolis, MN, 3University of Minnesota, Minneapolis, MN

    *Purpose: In the United States, priority on the liver transplant waitlist is determined by the model for end-stage liver disease (MELD)-Na, a score composed of…
  • 2022 American Transplant Congress

    Do Social Support Requirements Delay Time to Listing Decision in Liver Candidates?

    M. Jesse1, A. Peleman1, M. Karrick1, F. Nimri1, N. Parikh2, A. Segal1, D. Moonka1, M. Abouljoud1, A. Yoshida1

    1Henry Ford Health System, Detroit, MI, 2University of Michigan, Ann Arbor, MI

    *Purpose: Social support requirements in the evaluation of transplant candidates have recently come under increased scrutiny. One criticism is that these requirements delay listing decisions.…
  • 2022 American Transplant Congress

    The Other Reasons for Waitlist Removal

    C. Martinez, J. Foutz, A. Placona, L. Cartwright

    United Network for Organ Sharing, Richmond, VA

    *Purpose: When a transplant program removes a candidate from the waitlist, they must either select a pre-defined removal code or type a response into the…
  • 1
  • 2
  • 3
  • …
  • 44
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences